Title : Effects of rosiglitazone on endothelial function, C-reactive protein, and components of the metabolic syndrome in nondiabetic patients with the metabolic syndrome.

Pub. Date : 2004 Feb 1

PMID : 14759393






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Compared with those receiving placebo, patients in the rosiglitazone group achieved significant reductions in fasting plasma insulin levels (-40%), homeostasis model assessment indexes (-45%), systolic and diastolic blood pressures, and high-sensitivity C-reactive protein levels (-31%). Rosiglitazone C-reactive protein Homo sapiens